A Phase II Study of Sorafenib and Ifosfamide as a Treatment for Patients With Sarcoma.

Trial Profile

A Phase II Study of Sorafenib and Ifosfamide as a Treatment for Patients With Sarcoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Ifosfamide; Sorafenib
  • Indications Osteosarcoma; Soft tissue sarcoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 May 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top